tiprankstipranks
Sophia expands deal with AstraZeneca to include MM approaches to oncology
The Fly

Sophia expands deal with AstraZeneca to include MM approaches to oncology

Sophia Genetics (SOPH) is partnering with AstraZeneca (AZN) to apply their multimodal technology and expertise to the biopharmaceutical company’s oncology portfolio. The multimodal approach will go beyond a single data modality, combining radiomics analysis of medical imaging data, molecular data, digital pathology, clinical and biologic data for a more comprehensive assessment of multimodal signatures leveraging proprietary AI and machine learning technology. Together, the companies will examine ways to accelerate clinical trials, support evidence generation for market access, and improve clinical decision-making, helping clinicians to select the best possible treatments… Multimodality will allow for the integration of clinical data in AZ’s trials with health system datasets on advanced molecular diagnostics, radiological and histological imaging and codified clinical data. SOPHiA GENETICS is able to support this vision in practice today. In parallel, SOPHiA GENETICS launched its own real-world DEEP-Lung-IV clinical study to leverage its multimodal machine learning-powered analytics capabilities to identify multimodal predictive signatures of response to immunotherapy for patients with advanced lung cancer. "AstraZeneca is a global leader in innovative oncology therapeutics and has built one of the most diverse and robust oncology portfolios and R&D pipelines in the industry. Building on our existing partnership with AstraZeneca, notably to expand access to HRD testing, we are incredibly excited to deepen our collaboration to multimodal approaches that will further enable their precision oncology capabilities," said Peter Casasanto, Chief BioPharma Officer of SOPHiA GENETICS

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on SOPH:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles